/Cardinal%20Health%2C%20Inc_%20logo%20on%20building%20by-%20JHVEPhoto%20via%20Shutterstock.jpg)
Valued at a market cap of $31.7 billion, Dublin, Ohio-based Cardinal Health, Inc. (CAH) is one of the largest U.S. pharmaceutical distributors and a leading nuclear pharmacy provider. It operates two segments - Pharmaceutical & Specialty Solutions and Global Medical Products & Distribution, supplying drugs, specialty services and medical products to healthcare providers worldwide. CAH is expected to release its fiscal Q3 2025 earnings results before the market opens on Thursday, May 1.
Ahead of this event, analysts expect the prescription drug distributor to report an adjusted profit of $2.15 per share, up 3.4% from $2.08 per share in the prior year's quarter. It has surpassed Wall Street's bottom-line estimates in the past four quarters. In Q2 2025, Cardinal Health exceeded the consensus adjusted EPS estimate by 10.3%.
